Jessica Yingling, Ph.D.
Jessica Yingling, Ph.D. is the president of Little Dog Communications. Little Dog clients represent the full range of biotechnology companies and include those developing novel therapeutics, diagnostics, and devices that can make a meaningful difference in the lives of patients. Prior to Little Dog, Jessica was director of corporate communications at Fate Therapeutics. Jessica earned her Ph.D. in biomedical sciences from UC San Diego and a B.S. with honors in biochemistry from the University of Arizona.
Articles by Jessica:
-
Biotech Briefing: Two San Diego Scientists Featured on Time’s Health Care 50 List
Plus: Ionis Research Leader Recognized for Breakthrough in Neurodegenerative Disease Treatments
Read More » -
Biotech Briefing: Reflexion Physical Therapy System Reduces Costs for Knee Surgeries
Plus: Allele Awarded NIH Grant to Develop Nanoantibody Approach for Sepsis
Read More » -
Biotech Briefing: Scientists Analyze the Genetics of Toxic Tides
Plus: Nobel Prize in Medicine Awarded to former Scripps Research postdoc
Read More » -
Biotech Briefing: Forge Therapeutics Gets Info from Achaogen to Develop New Antibiotics
Plus: Cell and Gene Meeting on the Mesa celebrates 13 years
Read More » -
Biotech Briefing: ViaCyte and CRISPR Therapeutics Partner for Type 1 Diabetes Cure
Plus: Biocom names under-40 Life Science Catalyst Award recipients
Read More » -
Biotech Briefing: Building a Better Brain-in-a-Dish to Accelerate Cognitive Function Studies
Plus: The story behind Amazon’s San Diego office and plans to employ 500 San Diegans
Read More » -
Biotech Briefing: UC San Diego to Receive National Award for Career Development in Glycosciences
Plus: BioFluidica’s microfluidic chip is designed for early cancer detection
Read More » -
Biotech Briefing: UC San Diego to Test Novel Drug Combo to Treat Breast Cancer
Plus: Scripps Research scientists develop inexpensive urine test for river blindness
Read More » -
Biotech Briefing: San Diego Region Recognized as a Top City for Fast-Growth Companies
Plus: Surfing legends and cancer researchers and survivors surf for a cure
Read More » -
Biotech Briefing: Salk Researchers Find a Dietary Supplement That Can Fight Bacteria
Plus: JLL’s Market Outlook Ranks San Diego Third in Life Science Markets
Read More » -
Biotech Briefing: UCSD and UCLA Lead the UC System in Commercializing Inventions
Plus: UC San Diego Researchers spin out Oxitope based on “oxidation hypothesis”
Read More » -
Biotech Briefing: Scripps Research Finds New Way to Fight Cancer
Plus: A La Jolla event educated the community on how the BRCA gene relates to breast cancer
Read More » -
Biotech Briefing: San Diego Researchers Make Connection Between Microbiome and Diabetes
Plus: The U.S. House of Representatives passes bill to repeal medical device tax
Read More » -
Biotech Briefing: Companies With Skilled Foreign Workers Are More Innovative and Profitable
Plus: San Marcos-based Ocean Reef Group’s diving masks saved lives in Thailand cave rescue
Read More » -
Biotech Briefing: UC San Diego Opens Center to Fight Malaria and Other Tropical Parasites
Plus: Kit Pogliano to be first female dean of UC San Diego Division of Biological Sciences and local event sparks frank discussion on biotech industry’s gender issues
Read More » -
Biotech Briefing: AbbVie and Calibr Advance Next-Generation CAR-T Therapies in San Diego
Plus: UCSD receives funds for using viruses to cure superbug infections, and a diabetic koala gets a smart device
Read More » -
Biotech Briefing: Diversity in Health Research Participants Important to Find Cures
Plus: Vertex expands global research hub in San Diego, and BlueNalu launches to advance “cellular aquaculture”
Read More » -
Biotech Briefing: San Diego Drug Discoveries Are Changing the Therapeutic Landscape
Plus: Scripps Research, Salk, and UCSD top ranked nationally for science research, and a new alliance formed to support women founders of STEM companies
Read More » -
Biotech Briefing: Robin Toft on Biotech’s Looming Talent Crisis
Plus: Call for best workplace in San Diego County, and Biocom appoints four new board members
Read More » -
Biotech Briefing: Bloom Science Targets Epilepsy by Treating Gut Microbiome
Plus: TSRI graduates its 26th class of doctoral students, diversity in biopharma makes sense (and money)
Read More » -
Biotech Briefing: Verge, UC San Diego, and VIB Collaborate on Parkinson’s Research
Plus: TSRI expands its board of directors, and Luna DNA wants to trade donated DNA for dividends
Read More »
